Although the exact function of the receptor in prostate cancer has not yet been clarified, these data indicate the importance of OR51E2 in the pathogenesis of prostate cancer and OR51E2, and its ligand may be a new target to better combat prostate cancer. This evidence concerns the gene OR51E2 and prostate cancer.